Metabolic dysfunction‐associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study
ABSTRACT Aims/Introduction The 2023 Delphi consensus recommended the use of new term, metabolic dysfunction‐associated steatotic liver disease (MASLD), aiming conceptual shift from the conventional non‐alcoholic fatty liver disease (NAFLD). The association between NAFLD and type 2 diabetes mellitus...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Journal of Diabetes Investigation |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/jdi.14315 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850118261823242240 |
|---|---|
| author | Kimiko Sakai Takuro Okamura Ema Toyokuni Hiroshi Okada Akihiro Obora Takao Kojima Masahide Hamaguchi Michiaki Fukui |
| author_facet | Kimiko Sakai Takuro Okamura Ema Toyokuni Hiroshi Okada Akihiro Obora Takao Kojima Masahide Hamaguchi Michiaki Fukui |
| author_sort | Kimiko Sakai |
| collection | DOAJ |
| description | ABSTRACT Aims/Introduction The 2023 Delphi consensus recommended the use of new term, metabolic dysfunction‐associated steatotic liver disease (MASLD), aiming conceptual shift from the conventional non‐alcoholic fatty liver disease (NAFLD). The association between NAFLD and type 2 diabetes mellitus (T2DM) development is well known. This study aimed to examine the correlation between MASLD and T2DM development, comparing their utility as predictors. Materials and Methods This retrospective cohort study obtained data from a medical health checkup program conducted at Asahi University Hospital, Japan, between 2004 and 2021. Logistic regression analysis was used to assess the association between MASLD and incident T2DM over 5 years. To compare the predictive utility of NAFLD and MASLD, receiver operating characteristic curves were drawn, followed by area under the curve (AUC) comparisons. Results In total, 15,039 participants (59.6% males; median [interquartile range {IQR}] age, 44 [38, 50] years) were included. Out of 2,682 participants meeting the criteria for MASLD, 234 individuals (8.7%) developed T2DM. Multivariate analysis revealed a significantly elevated risk of T2DM in MASLD compared with the reference healthy group (without steatotic liver disease or cardiometabolic risk), presenting an OR of 127.00 (95% CI 40.40–399.00, P < 0.001). The concordance rate of diagnosis between NAFLD and MASLD was 98.7%. The AUC values were 0.799 for NAFLD and 0.807 for MASLD, respectively. Comparative analysis of the AUC showed a statistical difference between NAFLD and MASLD (P < 0.001). Conclusions MASLD was shown to be a significant risk factor for incident T2DM, exhibiting a potentially higher predictive capacity than conventional NAFLD. |
| format | Article |
| id | doaj-art-d0dabbae43224a6da7973a3aeea8fff7 |
| institution | OA Journals |
| issn | 2040-1116 2040-1124 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Diabetes Investigation |
| spelling | doaj-art-d0dabbae43224a6da7973a3aeea8fff72025-08-20T02:35:54ZengWileyJournal of Diabetes Investigation2040-11162040-11242024-12-0115121788179610.1111/jdi.14315Metabolic dysfunction‐associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA studyKimiko Sakai0Takuro Okamura1Ema Toyokuni2Hiroshi Okada3Akihiro Obora4Takao Kojima5Masahide Hamaguchi6Michiaki Fukui7Department of Endocrinology and Metabolism, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanDepartment of Endocrinology and Metabolism, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanDepartment of Endocrinology and Metabolism, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanDepartment of Endocrinology and Metabolism, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanDepartment of Gastroenterology Asahi University Hospital Gifu JapanDepartment of Gastroenterology Asahi University Hospital Gifu JapanDepartment of Endocrinology and Metabolism, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanDepartment of Endocrinology and Metabolism, Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto JapanABSTRACT Aims/Introduction The 2023 Delphi consensus recommended the use of new term, metabolic dysfunction‐associated steatotic liver disease (MASLD), aiming conceptual shift from the conventional non‐alcoholic fatty liver disease (NAFLD). The association between NAFLD and type 2 diabetes mellitus (T2DM) development is well known. This study aimed to examine the correlation between MASLD and T2DM development, comparing their utility as predictors. Materials and Methods This retrospective cohort study obtained data from a medical health checkup program conducted at Asahi University Hospital, Japan, between 2004 and 2021. Logistic regression analysis was used to assess the association between MASLD and incident T2DM over 5 years. To compare the predictive utility of NAFLD and MASLD, receiver operating characteristic curves were drawn, followed by area under the curve (AUC) comparisons. Results In total, 15,039 participants (59.6% males; median [interquartile range {IQR}] age, 44 [38, 50] years) were included. Out of 2,682 participants meeting the criteria for MASLD, 234 individuals (8.7%) developed T2DM. Multivariate analysis revealed a significantly elevated risk of T2DM in MASLD compared with the reference healthy group (without steatotic liver disease or cardiometabolic risk), presenting an OR of 127.00 (95% CI 40.40–399.00, P < 0.001). The concordance rate of diagnosis between NAFLD and MASLD was 98.7%. The AUC values were 0.799 for NAFLD and 0.807 for MASLD, respectively. Comparative analysis of the AUC showed a statistical difference between NAFLD and MASLD (P < 0.001). Conclusions MASLD was shown to be a significant risk factor for incident T2DM, exhibiting a potentially higher predictive capacity than conventional NAFLD.https://doi.org/10.1111/jdi.14315Liver steatosisNon‐alcoholic fatty liver diseaseType 2 diabetes mellitus |
| spellingShingle | Kimiko Sakai Takuro Okamura Ema Toyokuni Hiroshi Okada Akihiro Obora Takao Kojima Masahide Hamaguchi Michiaki Fukui Metabolic dysfunction‐associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study Journal of Diabetes Investigation Liver steatosis Non‐alcoholic fatty liver disease Type 2 diabetes mellitus |
| title | Metabolic dysfunction‐associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study |
| title_full | Metabolic dysfunction‐associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study |
| title_fullStr | Metabolic dysfunction‐associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study |
| title_full_unstemmed | Metabolic dysfunction‐associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study |
| title_short | Metabolic dysfunction‐associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study |
| title_sort | metabolic dysfunction associated steatotic liver disease a superior predictor for incident type 2 diabetes over traditional criteria nagala study |
| topic | Liver steatosis Non‐alcoholic fatty liver disease Type 2 diabetes mellitus |
| url | https://doi.org/10.1111/jdi.14315 |
| work_keys_str_mv | AT kimikosakai metabolicdysfunctionassociatedsteatoticliverdiseaseasuperiorpredictorforincidenttype2diabetesovertraditionalcriterianagalastudy AT takurookamura metabolicdysfunctionassociatedsteatoticliverdiseaseasuperiorpredictorforincidenttype2diabetesovertraditionalcriterianagalastudy AT ematoyokuni metabolicdysfunctionassociatedsteatoticliverdiseaseasuperiorpredictorforincidenttype2diabetesovertraditionalcriterianagalastudy AT hiroshiokada metabolicdysfunctionassociatedsteatoticliverdiseaseasuperiorpredictorforincidenttype2diabetesovertraditionalcriterianagalastudy AT akihiroobora metabolicdysfunctionassociatedsteatoticliverdiseaseasuperiorpredictorforincidenttype2diabetesovertraditionalcriterianagalastudy AT takaokojima metabolicdysfunctionassociatedsteatoticliverdiseaseasuperiorpredictorforincidenttype2diabetesovertraditionalcriterianagalastudy AT masahidehamaguchi metabolicdysfunctionassociatedsteatoticliverdiseaseasuperiorpredictorforincidenttype2diabetesovertraditionalcriterianagalastudy AT michiakifukui metabolicdysfunctionassociatedsteatoticliverdiseaseasuperiorpredictorforincidenttype2diabetesovertraditionalcriterianagalastudy |